Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Harvard Bioscience Inc

HBIO ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$6.66

▼ -0.22%

Market Cap $30.30M · Vol 5.01K

Key Metrics

P/E Ratio

N/A

FWD: 49.35

Market Cap

$30.30M

Micro Cap

Div Yield

N/A

EPS Growth

-242.50%

YoY

RSI (14)

67.18

Momentum

Beta

1.51

vs Market

52W High

$9.40

29.19% below

52W Low

$3.78

76.06% above

Volume

5.01K

Avg 3.96K

P/B

2.18

Price-to-book

ROE

-2.60%

Return on equity

Free Float

90.61%

Public shares

Shariah Compliance8 STANDARDS

✗ Harvard Bioscience Inc (HBIO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HBIO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.86%

+12.23%

+20.56%

+20.00%

YTD

-0.49%

+35.98%

-84.30%

-92.13%

Financials & Valuation

TTM · Annual

Total Revenue	$86.55M
Net Income	$-56,700,000.00
Revenue Growth (YoY)	+11.13%
Gross Margin	53.01%
Operating Margin	-0.51%
Net Profit Margin	-65.51%
ROE	-2.60%
ROA · ROIC	-55.52% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	49.35
PEG Ratio	N/A
P/S	0.34
P/B	2.18
P/FCF	6.10
EPS Growth	-242.50%
Outstanding Shares	4.55M

Technical Indicators

50-Day SMA	$6.17
200-Day SMA	$6.05
RSI (14)	67.18
Beta	1.51
52-Week High	$9.40
52-Week Low	$3.78

Volume Today	5.01K
Avg Daily Volume (30D)	3.96K
Relative Volume	1.27x
Volatility (10D)	53.05
Volatility (30D)	45.24
Free Float	90.61%

Analyst Consensus

BUY

Current Price $6.66

Mean Target $7.50

52W Low$3.78 52W High$9.40

Current

Target

$3.78 $9.40

Current Analyst target

+12.70% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SG1ML8

ISINUS4169062043

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 6, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.